NCT05619367 2025-12-23A Compassionate Use (CU) Program of OdronextamabRegeneron PharmaceuticalsAvailable
NCT06872489 2025-07-23Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsSecond Life TherapeuticsAvailable